1.72
+0.19(+12.42%)
Currency In USD
Previous Close | 1.53 |
Open | 1.53 |
Day High | 1.73 |
Day Low | 1.53 |
52-Week High | 3 |
52-Week Low | 1 |
Volume | 82,418 |
Average Volume | 116,277 |
Market Cap | 11.89M |
PE | -1.29 |
EPS | -1.33 |
Moving Average 50 Days | 1.46 |
Moving Average 200 Days | 1.63 |
Change | 0.19 |
If you invested $1000 in Intelligent Bio Solutions Inc. (INBS) since IPO date, it would be worth $0.65 as of June 30, 2025 at a share price of $1.72. Whereas If you bought $1000 worth of Intelligent Bio Solutions Inc. (INBS) shares 3 years ago, it would be worth $10.82 as of June 30, 2025 at a share price of $1.72.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia
GlobeNewswire Inc.
Jun 25, 2025 12:30 PM GMT
With over 450 accounts across 24 countries, INBS continues to advance the evolution of drug screening technologyNEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technolog
Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion
GlobeNewswire Inc.
Jun 18, 2025 12:30 PM GMT
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that Managed Waste Serv
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing
GlobeNewswire Inc.
Jun 11, 2025 12:30 PM GMT
SMARTOX has deployed over 50 of INBS’ Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more than 1,500 tests in 2024 alone Company continues to actively pursue FDA clearance in connection with pl